Amisure IV Injection Injection

About Amisure IV Injection 5 mg/2 ml

Made by The ACME Laboratories Ltd., Amisure IV Injection is a injection whose active ingredient is Amisulpride. Some patients mainly have negative symptoms.

There are 5 brands of Amisulpride listed in Bangladesh. The lowest listed price is Aride 100 mg Tablet at ৳ 30.00 per unit.

What is Amisure IV Injection 5 mg/2 ml?

The injection Amisure IV Injection contains Amisulpride and is made by The ACME Laboratories Ltd. It is a prescription medicine, so the dose, how often it is taken and how long the course lasts are decided by the doctor. That contains Amisulpride, classed as an atypical neuroleptic drug. The dose and course are decided by the treating doctor based on the individual patient.

Uses of Amisure IV Injection

Some patients mainly have negative symptoms. Only a qualified doctor can decide whether this medicine is suitable for a particular person, and the doctor sets the dose and course. It is also used for patients whose illness is characterised mainly by negative symptoms. Ask your doctor whether it is right for your condition.

How to use Amisure IV Injection

The dose, how often it is given and how long treatment continues are decided by the treating doctor and may be adjusted to the individual patient's response. Amisure IV Injection is given as an injection by a healthcare professional. Do not inject it yourself unless a doctor has shown you how. Do not take more than the doctor advises. If you miss a dose, ask your doctor or pharmacist what to do. Complete the course exactly as prescribed.

Side effects of Amisure IV Injection

Neuroleptic malignant syndrome is a potentially fatal reaction that has been reported with antipsychotic medicines including Amisulpride; it is characterised by high fever, muscle rigidity, unstable autonomic function and raised CPK. Ask the doctor or pharmacist about other possible side effects. Tell your doctor if any side effect bothers you or does not go away.

Safety and precautions

Amisure IV Injection injection should not be used by anyone with hypersensitivity to Amisulpride or other ingredients of the product. It is contraindicated with prolactin-dependent tumours such as pituitary prolactinomas and breast cancer, with phaeochromocytoma, in children up to puberty, and during breastfeeding. Patients with a history of seizures need close monitoring. Tell your doctor about all the other medicines you take.

Frequently asked questions

What is Amisure IV Injection used for?

Some patients mainly have negative symptoms. Only a qualified doctor can decide whether this medicine is suitable for a particular person, and the doctor sets the dose and course.

How do I use Amisure IV Injection correctly?

The dose, how often it is given and how long treatment continues are decided by the treating doctor and may be adjusted to the individual patient's response. Amisure IV Injection is given as an injection by a healthcare professional.

Can Amisure IV Injection cause side effects?

Neuroleptic malignant syndrome is a potentially fatal reaction that has been reported with antipsychotic medicines including Amisulpride; it is characterised by high fever, muscle rigidity, unstable autonomic function and raised CPK. Ask the doctor or pharmacist about other possible side effects.

Can I use Amisure IV Injection in pregnancy or while breastfeeding?

Amisure IV Injection injection should not be used by anyone with hypersensitivity to Amisulpride or other ingredients of the product. It is contraindicated with prolactin-dependent tumours such as pituitary prolactinomas and breast cancer, with phaeochromocytoma, in children up to puberty, and during breastfeeding.

Indications

Amisulpride tablet is indicated for the treatment of acute and chronic schizophrenic disorders, in which positive symptoms (such as delusions, hallucinations, thought disorders) and/or negative symptoms (such as blunted affect, emotional and social withdrawal) are prominent, including ... Read moreAmisulpride tablet is indicated for the treatment of acute and chronic schizophrenic disorders, in which positive symptoms (such as delusions, hallucinations, thought disorders) and/or negative symptoms (such as blunted affect, emotional and social withdrawal) are prominent, including patients characterized by predominant negative symptoms.

Amisulpride injection is indicated in adults for:
  • Prevention of postoperative nausea and vomiting (PONV), either alone or in combination with an antiemetic of a different class.
  • Treatment of postoperative nausea and vomiting (PONV) in patients who have received antiemetic prophylaxis with an agent of a different class or have not received prophylaxis.

Pharmacology

Amisulpride binds selectively to the human dopaminergic D2 and D3 receptor subtypes without any affinity for D1, D4 and D5 receptor subtypes. Unlike classical and atypical neuroleptics, amisulpride displays low affinity for serotonin, α- adrenergic, histamine receptor subtypes, muscarinic receptors and sigma sites. In the rodent, it preferentially blocks post synaptic D2 receptors located in the limbic structures as compared to those in the striatum as indicated by its reversal of d-amphetamineinduced hyperactivity without affecting stereotypies. In addition, it does not induce catalepsy and it does not produce D2 hypersensitivity after repeated treatment.

Moreover, it preferentially blocks pre-synaptic D2/D3 dopamine receptors, producing dopamine release responsible for its disinhibitory effects. This atypical pharmacological profile may explain amisulpride’s antipsychotic effect at higher doses through post-synaptic dopamine receptor blockade located in the limbic areas and its efficacy against negative symptoms, at lower doses, through presynaptic dopamine receptor blockade. In addition, the reduced tendency of amisulpride to produce extrapyramidal side effects may be related to its preferential limbic activity.

Dosage & Administration

Oral dose: For acute psychotic episodes, oral doses between 400 mg/d and 800 mg/d are recommended. In individual cases, the daily dose may be increased up to 1200 mg/d. Doses above 1200 mg/d have not been extensively evaluated for safety and therefore should not be used. Doses above 800 mg/d have not been shown to be superior to lower doses and may increase the incidence of adverse events. No specific titration is required when initiating the treatment with amisulpride.

Doses should be adjusted according to individual responses. Doses should preferably be administered before meals. Amisulpride should be administered twice daily for doses above 400 mg. For patients with mixed positive and negative symptoms, doses should be adjusted to obtain optimal control of positive symptoms. Maintenance treatment should be established individually with the minimally effective dose. For patients characterized by predominant negative symptoms, oral doses between 50 mg/d and 300 mg/d are recommended. Doses should be adjusted individually.

Injectable dose: The recommended injectable adult dosage of Amisulpride and infusion rate by indication is shown in the table below:
  • Prevention of postoperative nausea and vomiting: 5 mg as a single intravenous injection infused over 1 to 2 minutes at the time of induction of anesthesia.
  • Treatment of postoperative nausea and vomiting: 10 mg as a single intravenous injection infused over 1 to 2 minutes in the event of nausea and/or vomiting after a surgical procedure.

Contraindications

Hypersensitivity to the active ingredient or to other ingredients of the product. Concomitant prolactin-dependent tumours e.g. pituitary gland prolactinomas and breast cancer. Phaeochromocytoma. Children up to puberty. Lactation.

Pregnancy & Lactation

pregnancy Category C. The safety of amisulpride during human pregnancy has not been established, and therefore use of amisulpride is not recommended during pregnancy and in women of child bearing potential not using effective contraception, unless the benefits justify the potential risks and the administered dose and duration of treatment should be as low and as short as possible. Amisulpride has been found in the breast milk of treated women. Breast-feeding is contraindicated.

Precautions & Warnings

Neuroleptic Malignant Syndrome (NMS) is a potentially fatal syndrome that has been reported in association with anti psychotic medicines, including amisulpride. Neuroleptic malignant syndrome is characterised by hyperthermia, muscle rigidity, autonomic instability, and elevated CPK, may occur. In the event of any symptoms which could suggest NMS, in particular hyperthermia, particularly with high daily doses, all antipsychotic medicines including amisulpride should be discontinued. Amisulpride can lower the seizure threshold. Therefore patients with a history of seizures should be closely monitored during amisulpride therapy.

Storage Conditions

Keep below 30°C temperature, away from light & moisture. Keep out of the reach of children.

Alternative brands of Amisulpride

Other brands with the same generic name, cheapest first.

Aride Tablet

100 mg

Amisulpride

Renata PLC.

৳ 29.4 ৳ 30.00 2% off per unit

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.